EphA2 kinase-dependent signaling has been linked to a variety of functional outcomes, such as suppression of the AKT–mTORC1 and RAS–ERK oncogenic pathways and inhibition of cell adhesion and migration/invasion, but also enhancement of cancer cell dispersal and promotion of tumor angiogenesis1–4, 8. Here, AKT1 is linked to cancer.